We found that high levels of EZH2 expression during cancer progression induce repression of TIMP genes (TIMP2 and TIMP3), leading to increased activity of MMP-9 and thus to increased invasive activity of prostate cancer cells. The gene discussed is EZH2; the disease is prostate carcinoma.